hydrolyzed sodium chondroitin sulfate hamilelikte güvenli mi?
No harmonised CLP reproductive classifications (ECHA Annex VI) nor SCCS/CIR findings indicating reproductive hazard for chondroitin derivatives; literature on chondroitin (oral or topical) does not report teratogenicity or human reproductive effects. The ingredient is a large hydrophilic glycosaminoglycan derivative with low systemic bioavailability from topical use, so reproductive hazard is not indicated (sources: ECHA Annex VI absence, CIR none, PubMed reviews of chondroitin safety, CosIng listing).
Related ingredients
Frequently asked questions
- hydrolyzed sodium chondroitin sulfate hamilelikte güvenli mi?
- No harmonised CLP reproductive classifications (ECHA Annex VI) nor SCCS/CIR findings indicating reproductive hazard for chondroitin derivatives; literature on chondroitin (oral or topical) does not report teratogenicity or human reproductive effects. The ingredient is a large hydrophilic glycosaminoglycan derivative with low systemic bioavailability from topical use, so reproductive hazard is not indicated (sources: ECHA Annex VI absence, CIR none, PubMed reviews of chondroitin safety, CosIng listing).
- hydrolyzed sodium chondroitin sulfate emzirirken güvenli mi?
- No evidence of reproductive or lactation-specific toxicity; molecule size and hydrophilicity make significant systemic absorption and transfer into breast milk unlikely. No harmonised classifications or CIR/SCCS opinions raising concern (sources: ECHA Annex VI absence, PubMed, CosIng, EWG).
- hydrolyzed sodium chondroitin sulfate bebek cildi için güvenli mi?
- Hazard and mechanism: no infant-specific reproductive/toxicologic evidence. Exposure: increased potential for percutaneous uptake in infants relative to adults is possible for substances with measurable dermal absorption; chondroitin derivatives are large, hydrophilic and expected to have negligible adult absorption, but because infant barrier is immature a conservative exposure score +1 is applied (adult e=0 → infant e=1). No data indicate infant-specific harms (sources: general dermal absorption principles, CosIng, PubMed).
- VeriMom hydrolyzed sodium chondroitin sulfate nasıl puanlıyor?
- VeriMom hydrolyzed sodium chondroitin sulfate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte hydrolyzed sodium chondroitin sulfate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.